Podcast thumbnail for seat11a - Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG

seat11a - Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG

Claim This Podcast

by seat11a.com

5.0(3 reviews)
440 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇩🇪
61

Podcast Authority

Beta
GoodBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality99
Social0
YouTube0
Engagement60

Podcast Overview

Investor Insights from CEOs & CFOs | seat11a features CEO interviews, CFO interviews, investor presentations, financial results, earnings presentations, elevator pitches, deep dives and strategy updates from publicly listed companies. Discover clear equity stories, business models, growth strategies, ESG updates, capital markets insights and stock market perspectives for private investors, portfolio managers, analysts and anyone following European stocks, global equities and listed company performance.

Language

🇺🇲

Publishing Since

1/28/2021

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

61

Podcast Authority

Beta
GoodBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality99
Social0
YouTube0
Engagement60
9
Excellent Areas
1
Good Performance
9
Growth Opportunities
excellent
Publishing Consistency
Every 4 days
Performing excellently!
good
iTunes Tags
6.5/10

Recommendations available

Unlock the full report to see detailed tips

poor
Episode Thumbnails

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

  • • YouTube presence analysis
  • • Social media reach metrics
  • • RSS compliance scoring
  • • Podcast 2.0 features
  • • Technical standards
What's Included in Your Full Report

Detailed Analytics

  • Complete breakdown of all 19 authority metrics
  • Personalized recommendations for each metric
  • Industry benchmarks and comparisons
  • Technical RSS feed analysis and compliance scoring

Growth Strategies

  • Step-by-step action plans for improvement
  • Quick wins to boost your score immediately
  • Pro tips from successful podcasters
Get your free podcast insights report

See how your show performs across every key metric

Instant delivery
No spam
Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

1 verified contact email on file for seat11a - Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for BRAIN Biotech Elevator Pitch | Enzyme, Biotechnologie und Wachstumsstrategie

July 8, 2026

BRAIN Biotech Elevator Pitch | Enzyme, Biotechnologie und Wachstumsstrategie

<p>In diesem seat11a Elevator Pitch stellt Michael Schneiders, CFO der BRAIN Biotech AG, das Geschäftsmodell, die Technologieplattform und die langfristige Wachstumsstrategie des Unternehmens vor.BRAIN Biotech ist ein Unternehmen der industriellen Biotechnologie und entwickelt Enzyme, Mikroorganismen sowie biologische Lösungen für Kunden aus den Bereichen Lebensmittel, Getränke, Life Sciences sowie weiteren Spezialmärkten. Mit seinen Produkten unterstützt das Unternehmen die Biologisierung industrieller Prozesse und den Übergang zu nachhaltigeren Produktionsverfahren.Das Geschäftsmodell basiert auf zwei komplementären Säulen. BRAINBiocatalysts bündelt das operative Geschäft mit Spezialenzymen, Mikroorganismen sowie Forschungs-, Entwicklungs- und Produktionsdienstleistungen. BRAINBioIncubator konzentriert sich auf innovative Entwicklungsprojekte, Beteiligungen sowie Lizenz- und Royalty-Modelle mit zusätzlichem Wertschöpfungspotenzial.Im Geschäftsjahr 2024/25 erzielte BRAIN Biotech einen Umsatz von rund 45,4 Mio. Euro, ein bereinigtes EBITDA von rund 4,4 Mio. Euro sowie wiederkehrende Erlöse von rund 4,2 Mio. Euro. Damit verbindet das Unternehmen ein profitables operatives Geschäft mit langfristigen Innovationsprojekten.Im Rahmen des Capital Markets Day 2024 stellte BRAIN Biotech ambitionierte mittelfristige Ziele vor. Für den Bereich BRAINBiocatalysts strebt das Unternehmen einen Umsatz von 100 Mio. Euro sowie eine bereinigte EBITDA-Marge von 15 % an. Ergänzend soll die erfolgreiche Kommerzialisierung von Projekten aus dem BRAINBioIncubator zusätzliche Wertschöpfung schaffen.Langfristig verfolgt BRAIN Biotech das Ziel, zu den Top 10 der weltweit führenden Spezialenzymunternehmen aufzusteigen und von den strukturellen Wachstumstrends in den Bereichen industrielle Biotechnologie, Spezialenzyme und nachhaltige biologische Lösungen zu profitieren. ▶️ Other videos:Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/Company Presentation: https://seat11a.com/investor-relations-company-presentation/Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ESG Presentation: https://seat11a.com/investor-relations-esg/T&amp;CThis publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.</p><p><br></p>

Episode thumbnail for BRAIN Biotech AG Elevator Pitch | Enzymes, Bioeconomy & Innovation

July 6, 2026

BRAIN Biotech AG Elevator Pitch | Enzymes, Bioeconomy & Innovation

<p>Key Takeaways</p><p><br /></p><p>BRAIN Biotech AG Elevator Pitch Presentation</p><p>In this seat11a Elevator Pitch, Michael Schneiders, CFO of BRAIN Biotech AG, presents the company’s business model, biotechnology platform, and long-term growth strategy.</p><p><br /></p><p>Biotechnology Platform for Sustainable Industrial Solutions</p><p>BRAIN Biotech develops enzyme products, microorganisms, and biological solutions that help customers replace conventional industrial processes with more sustainable biotechnology-based alternatives. The company serves customers across food, beverage, life sciences, proteins, dairy, and other specialty industrial markets through its integrated biotechnology platform.</p><p><br /></p><p>Two Complementary Business Pillars</p><p>The business is built around two complementary pillars. The BRAINBiocatalysts division develops and produces specialty enzymes and microbial solutions while providing contract research and manufacturing services. The BRAINBioIncubator focuses on breakthrough innovation projects, strategic participations, and pharmaceutical royalty opportunities that have the potential to create significant additional value over time.</p><p><br /></p><p>Balanced Business Model and Financial Performance</p><p>Management explains how this combination creates a balanced business model, generating profitable operating revenues while maintaining exposure to higher-value innovation projects. During FY 2024/25, BRAIN Biotech generated approximately €45.4 million in annual revenue, €4.4 million adjusted EBITDA, and approximately €4.2 million in recurring revenues, providing a solid financial foundation for future growth.</p><p><br /></p><p>Medium-Term Growth Targets and Expansion Strategy</p><p>Looking ahead, the company has set ambitious medium-term objectives presented at its 2024 Capital Markets Day. Within its BRAINBiocatalysts division, management targets €100 million in revenue together with an adjusted EBITDA margin of 15%, supported by organic growth and acquisitions. At the same time, BRAINBioIncubator continues to offer additional upside through the commercialization of innovative biotechnology projects.</p><p><br /></p><p>Long-Term Growth Drivers in Industrial Biotechnology</p><p>The presentation also explains how BRAIN Biotech benefits from long-term structural trends including sustainable manufacturing, biologization of industrial processes, growing demand for specialty enzymes, and increasing adoption of biological solutions across multiple industries. Management’s long-term ambition is to establish BRAIN Biotech as one of the Top 10 global enzyme companies.</p><p><br /></p><p><br /></p><p> ▶️ Other videos:</p><p><br /></p><p>Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/</p><p>Company Presentation: https://seat11a.com/investor-relations-company-presentation/</p><p>Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/</p><p>Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/</p><p>ESG Presentation: https://seat11a.com/investor-relations-esg/</p><p><br /></p><p>T&amp;C</p><p>This publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.</p>

Episode thumbnail for eDreams ODIGEO Deep Dive | How eDreams Uses AI

June 5, 2026

eDreams ODIGEO Deep Dive | How eDreams Uses AI

<p>eDreams ODIGEO&#39;s Deep Dive: Key Takeaways</p><p>eDreams ODIGEO Artificial Intelligence Deep Dive</p><p>In this deep dive presentation on seat11a, David Elizaga explains how Artificial Intelligence has become a core component of eDreams ODIGEO’s business model and long-term growth strategy.</p><p><br></p><p>Artificial Intelligence as a Core Business Component</p><p>Management describes eDreams as an AI-first company for more than a decade, emphasizing that AI has been integrated into the business long before the recent surge of interest in generative AI technologies. Today, AI supports multiple areas of the company, including customer acquisition, software development, customer service, pricing, marketing, and product innovation.</p><p><br></p><p>Prime Subscription Ecosystem and Proprietary Travel Platform</p><p>A central part of the strategy is the combination of the company’s proprietary travel platform and its Prime subscription ecosystem. With approximately 8 million Prime subscribers, eDreams benefits from a large base of repeat customers, reducing dependence on highly competitive performance marketing channels and creating a relationship-based customer model that management views as a significant competitive advantage.</p><p><br></p><p>Agentic AI and Customer Acquisition</p><p>The company also sees emerging opportunities through Agentic AI. Management believes AI-powered travel assistants could become an additional customer acquisition channel while simultaneously enhancing customer experience and strengthening product capabilities. eDreams expects AI to support future growth by improving personalization, customer interactions, and operational efficiency.</p><p><br></p><p>AI Productivity Gains in Software Development</p><p>The operational impact of AI is already visible across the organization. During FY26, AI-assisted development contributed to a 47% increase in productivity, while some engineering teams now generate code entirely through AI-assisted workflows that are subsequently reviewed by humans. Agentic development has enabled the company to deliver five times more business features than before.</p><p><br></p><p>AI in Customer Service and Cost Efficiency</p><p>Customer service has also benefited from AI adoption. Approximately 30% of support calls are now solved by AI, while customer satisfaction levels remain comparable to human-assisted interactions. In addition, AI-supported automation contributed to a 13% reduction in customer service costs during FY26.</p><p><br></p><p>AI-Driven Pricing and Marketing Capabilities</p><p>Across marketing and pricing, AI is increasingly used to optimize commercial activities. The company reported a 24% increase in AI-driven pricing capabilities, while AI-generated marketing content expanded significantly, helping reduce external production costs by 75% while maintaining a stable headcount.</p><p><br></p><p>Artificial Intelligence Supporting Long-Term Growth</p><p>Overall, the presentation demonstrates how eDreams ODIGEO is applying Artificial Intelligence across its business operations and how management sees AI supporting future innovation, productivity, customer engagement, and long-term growth.</p><p><br></p><p>▶️ Other videos:</p><p><br></p><p>Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/</p><p>Company Presentation: https://seat11a.com/investor-relations-company-presentation/</p><p>Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/</p><p>Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/</p><p>ESG Presentation: https://seat11a.com/investor-relations-esg/</p><p><br></p><p>T&amp;C</p><p>This publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.</p>

440 total episodes available

Recent guests on seat11a - Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG

Guests from recent episodes — sign up to see every guest that has ever appeared on this show.

Sebastian Frericks

Guest

David

Guest

Michael Schneiders

Guest

Dr. Markus Weber

Guest

Justus Felix Wehmer

Guest

Deep-dive analytics for seat11a - Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is seat11a - Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG?

Investor Insights from CEOs & CFOs |

seat11a features CEO interviews, CFO interviews, investor presentations, financial results, earnings presentations, elevator pitches, deep dives and strategy updates from publicly listed companies.

Discover clear equity stories, business models, growth strategies, ESG updates, capital markets insights and stock market perspectives for private investors, portfolio managers, analysts and anyone following European stocks, global equities and listed company performance.

How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.